Literature DB >> 1747954

Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection.

H E Feucht1, E Felber, M J Gokel, G Hillebrand, U Nattermann, C Brockmeyer, E Held, G Riethmüller, W Land, E Albert.   

Abstract

Complement activation in 73 renal transplant biopsies was investigated by indirect immunoperoxidase staining using MoAbs reactive with complement-split products. Intense deposition of complement fragments C4d and C3d in peritubular capillaries, indicating activation of the classical pathway, could be detected in the majority of transplanted kidneys with cell-mediated rejections. Abundant deposition of complement-split products was observed in 22 early biopsies from patients with high 'immunological risk' (i.e. previous, rejected transplants and/or circulating antibodies against HLA-antigens). Despite negative results in the crossmatch before transplantation and paucity of immunoglobulins in transplant biopsies, antibodies directed against endothelial cell antigens should be considered as a possible cause of classical complement activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747954      PMCID: PMC1554190          DOI: 10.1111/j.1365-2249.1991.tb02954.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation.

Authors:  R M Marks; R F Todd; P A Ward
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

3.  Hyperacute rejection of the kidney in patients with a negative crossmatch.

Authors:  B Banner; L Makowka; J Demetris; A Tzakis; M Griffin; T E Starzl
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

Review 4.  Human renal allografts. The role of vascular injury in early graft failure.

Authors:  G J Busch; E S Reynolds; E G Galvanek; W E Braun; G J Dammin
Journal:  Medicine (Baltimore)       Date:  1971-01       Impact factor: 1.889

5.  Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.

Authors:  J Arvieux; H Yssel; M G Colomb
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

6.  Linear C3 deposits on the tubular basement membrane in renal allograft biopsies.

Authors:  M Mathew; W K Bolton
Journal:  Am J Kidney Dis       Date:  1988-08       Impact factor: 8.860

Review 7.  Structure and function of the anaphylatoxins.

Authors:  T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1984

8.  Complement activation in human lymphoid germinal centres.

Authors:  J Zwirner; E Felber; P Schmidt; G Riethmüller; H E Feucht
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

9.  Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis.

Authors:  Y Kusunoki; N Itami; H Tochimaru; Y Takekoshi; S Nagasawa; T Yoshiki
Journal:  Nephron       Date:  1989       Impact factor: 2.847

10.  Classical pathway of complement activation in normal and diseased human glomeruli.

Authors:  J Zwirner; E Felber; V Herzog; G Riethmüller; H E Feucht
Journal:  Kidney Int       Date:  1989-12       Impact factor: 10.612

View more
  66 in total

1.  In situ localization of C3 synthesis in experimental acute renal allograft rejection.

Authors:  J R Pratt; K Abe; M Miyazaki; W Zhou; S H Sacks
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 2.  The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

Authors:  Alexandre Loupy; Gary S Hill; Stanley C Jordan
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

Review 3.  The emerging role of complement inhibitors in transplantation.

Authors:  Véronique Frémeaux-Bacchi; Christophe M Legendre
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

4.  In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.

Authors:  Takafumi Yagisawa; Toshiaki Tanaka; Satoshi Miyairi; Kazunari Tanabe; Nina Dvorina; Wayne M Yokoyama; Anna Valujskikh; William M Baldwin; Robert L Fairchild
Journal:  Kidney Int       Date:  2018-11-29       Impact factor: 10.612

Review 5.  Chronic allograft nephropathy in paediatric renal transplantation.

Authors:  Stephen I Alexander; Jeffrey T Fletcher; Brian Nankivell
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

Review 6.  [The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection].

Authors:  Helmut E Feucht
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

Review 7.  [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions].

Authors:  Georg Böhmig
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

8.  Red blood cell age and potentiation of transfusion-related pathology in trauma patients.

Authors:  Jordan A Weinberg; Scott R Barnum; Rakesh P Patel
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

9.  Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice.

Authors:  T Hirohashi; S Uehara; C M Chase; P DellaPelle; J C Madsen; P S Russell; R B Colvin
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

Review 10.  New concepts of complement in allorecognition and graft rejection.

Authors:  Barbara A Wasowska; Chih-Yuan Lee; Marc K Halushka; William M Baldwin
Journal:  Cell Immunol       Date:  2007-10-24       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.